Hyperhemolysis in Patients With Hemoglobinopathies: A Single-Center Experience and Review of the Literature

Transfusion Medicine Reviews

Volumn 29, Issue 4, 2015, Pages 220-230

  Danaee, Anicee ^a   Inusa, Baba ^b   Howard, Jo ^a   Robinson, Susan ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Hyperhemolysis; Sickle cell disease; Transfusion reaction

Indexed keywords

ALLOANTIBODY; ERYTHROPOIETIN; FERRIC CARBOXYMALTOSE; FOLIC ACID; HYDROXOCOBALAMIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; AUTOANTIBODY; BLOOD GROUP RHESUS SYSTEM; HLA ANTIGEN;

ADULT; AGED; ANEMIA; ARM PAIN; ASSISTED VENTILATION; BLOOD GROUP RHESUS SYSTEM; CHILD; CLINICAL ARTICLE; CYANOCOBALAMIN DEFICIENCY; DISEASE ASSOCIATION; ERYTHROCYTE TRANSFUSION; FEMALE; FEVER; GENOTYPE; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN H DISEASE; HEMOGLOBIN SC DISEASE; HEMOLYSIS; HUMAN; HYPERHEMOLYSIS; LABORATORY DIAGNOSIS; LEG PAIN; MACROPHAGE ACTIVATION; MALE; PATHOPHYSIOLOGY; REVIEW; RISK ASSESSMENT; SCHOOL CHILD; SICKLE CELL ANEMIA; URINE COLOR; YOUNG ADULT; ADOLESCENT; ADVERSE EFFECTS; BLOOD; BLOOD GROUP INCOMPATIBILITY; BLOOD TRANSFUSION; COMPLICATION; GENETICS; HEMOGLOBINOPATHIES; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGY; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; BLOOD GROUP INCOMPATIBILITY; BLOOD TRANSFUSION; CHILD; FEMALE; GENOTYPE; HEMOGLOBINOPATHIES; HEMOLYSIS; HLA ANTIGENS; HUMANS; MACROPHAGE ACTIVATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RH-HR BLOOD-GROUP SYSTEM; YOUNG ADULT;

EID: 84941944468     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2015.06.001     Document Type: Review

References (60)

1. Diamond J.W., Brown F.L., Bitterman P., Klein H.G., Davey R.J., Winslow R.M. Delayed haemolytic transfusion reaction presenting as sickle cell crisis. Ann Intern Med 1980, 93:231-233.
2. Cullis J.O., Win N., Dudley J.M., Kaye T. Post transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction. Vox Sang 1995, 69:355-357.
3. King K.E., Shirley R.S., Lankiewicz M.W., Young-Ramsaran J., Ness P.M. Delayed haemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells. Transfusion 1997, 37:376-381.
4. Petz L.D., Calhoun L., Shulman I.A., Johnson C., Herron R.M. The sickle haemolytic transfusion reaction syndrome. Transfusion 1997, 37:382-392.
5. Sirchia G., Moerlati F., Rebulla P. The sickle haemolytic transfusion reaction syndrome. Transfusion 1997, 37:1098-1099.
6. Grainger J.D., Makar Y., McManus A., Wynn R. Refractory hyperhaemolysis in a patient with beta-thalassaemia major. Transfus Med 2001, 11:55-57.
7. Win N., Doughty H., Telfer P., Wild B.J., Pearson J.C. Hyperhemolytic transfusion reaction in sickle cell disease. Transfusion 2001, 41:323-328.
8. Aygun B., Padmanabhan B., Paley C., Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002, 42:37-43.
9. Talano J.A., Hillery C.A., Gottschal J.L., Baylerian D.M., Scott J.P. Delayed haemolytic reaction/hyperhemolysis syndrome in children with sickle cell disease. Paediatrics 2003, 111:661-665.
10. Win N., Yegehn T., Needs M., Chen F.E., Okpala I. Use of intravenous immunoglobulin and intravenous methylprednisolone in hyperhaemolysis syndrome in sickle cell disease. Hematology 2004, 9:433-436.
11. McGlennan A.P., Grundy E.M. Delayed haemolytic transfusion reaction and hyperhaemolysis complicating peri-operative blood transfusion in sickle cell disease. Anaesthesia 2005, 60:609-612.
12. Noizat-Pirenne F., Bachir D., Chadebeh P., Michel M., Plonquet A., Lecron J.C., et al. Rituximab for the prevention of delayed haemolytic transfusion reaction in sickle cell disease. Haematologica 2007, 92:e132-e135.
13. Win N., New H., Lee E., de la Fuente J. Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review. Transfusion 2008, 48:1231-1238.
14. Senanayake M.P., Kuruppu K.K., Sumanasena S.P., Lamabadusuriya S.P. Hyperhaemolysis syndrome in haemoglobin E/beta thalassaemia responding to cyclophosphomide therapy. Ceylon Med J 2008, 53:134-135.
15. Reyes M.A., Illoh O.C. Hyperhemolytic transfusion reaction attributable to anti-Fy3 in a patient with sickle cell disease. Immunohematology 2008, 24:45-51.
16. Morawakage L.R., Perera B.J.C., Dias P.D., Wijewardana S.K. Hyperhemolysis in a patient with β-thalassemia major. Asian J Transfus Sci 2009, 3:26-27.
17. Islam M.S., Chia L. Hyperhemolysis syndrome in a patient with sickle cell disease with erythrophagocytosis in peripheral blood. Eur J Haematol 2010, 84:188.
18. Bachmeyer C., Maury J., Parrot A., Bachir D., Stankovic K., Girot R., et al. Rituximab as an effective treatment of hyperhaemolysis syndrome in sickle cell anaemia. Am J Hematol 2009, 85:91-92.
19. Hannema S., Brand A., Van Meurs A., Smiers F.J. Delayed haemolytic transfusion reaction with hyperhemolysis after first red blood cell transfusion in child with β-thalassemia: challenges in treatment. Transfusion 2010, 50:429-432.
20. Stokes I.C., Downie P.A., Wood E.M., Bowden D.K., Monagle P.T., Barnes C.D. Hyperhaemolysis in sickle cell disease-an unusual and potentially life-threatening complication. Med J Aust 2010, 192:281-282.
21. Win N., Sinha S., Lee E., Mills W. Treatment with intravenous immunoglobulin and steroids may correct the severe anaemia in hyperhaemolytic transfusion reaction: case report and literature review. Transfus Med Rev 2010, 24:64-67.
22. El-Husseini A., Sabry A. Fatal hyperhemolytic delayed transfusion reaction in sickle cell disease: a case report and literature review. Am J Emerg Med 2010, 88:1062.e5-1062.e8.
23. Mechery J., Abidogun K., Crosfill F., Jip J. Hyperhemolysis syndrome complicating pregnancy in homozygous δβ-thalassemia. Hemoglobin 2012, 36:183-185.
24. de Montalembert M., Dumont M.D., Heilbronner C., Brousse V., Charrara O., Pellegrino B., et al. Delayed haemolytic transfusion reaction in children with sickle cell disease. Haematologica 2011, 96:801-807.
25. Win N., Lee E., Needs M., Chia L.W., Stasi R. Measurement of macrophage marker in hyperhaemolytic transfusion reaction a case report. Transfus Med 2012, 22:137-141.
26. Aragona E., Kelly M.J. Hyperhemolysis in sickle cell disease. J Pediatr Hematol Oncol 2014, 36:e54-e56.
27. Uhlmann E.J., Shenoy S., Goodnough L.T. Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion. Transfusion 2014, 54:384-388.
28. Vagace J.M., Casaso M.S., Bajo R., Gervasini G. Hyperhaemolysis syndrome responsive to splenectomy in a patient with δβ-thalassaemia: a discussion on underlying mechanisms. Blood Transfus 2014, 12:127-129.
29. Ipe T.S., Wilkes J.J., Hartung H.D., Westhoff C.M., Chou S.T., Friedman D.F. Severe hemolytic transfusion reaction due to anti-D in a D+ patient with sickle cell disease. J Pediatr Hematol Oncol 2015, 37:e135-e137.
30. Danaee A., Robertson B., Howard J., Robinson S. Hyperhaemolysis in a patient with HbH disease. Transfus Med 2014, 24:244-245.
31. Treleaven J.G., Win N. Hyperhaemolysis in a patient with myelofibrosis. Hematology 2004, 9:147-149.
32. Darabi K., Dzik S. Hyperhaemolysis syndrome in anaemia of chronic disease. Transfusion 2005, 45:1930-1933.
33. Babb A., Diamantos N., Sekhar M. Hyperhaemolysis syndrome treated with corticosteroids and darbopoietin in a patient with mantle cell lymphoma. Transfus Med 2012, 22:142-144.
34. Bank I., Ermen A., Van Der Linden J.M., Brand A. A life threatening episode of treatment resistant haemolysis in a pregnant patient with dyserythropoeitic anaemia (CDA) type I. Transfus Med 2012, 22:145-147.
35. Rogers M., Smith G. Hyperhaemolysis in a patient with chronic lymphocytic leukaemia. Transfus Med 2014, 24:123-124.
36. Gupta S., Fenves A., Nance S.T., Sykes D.B., Dzik W.S. Hyperhemolysis syndrome in a patient without hemoglobinopathy, unresponsive to treatment with eculizumab. Transfusion 2015, 55:623-628.
37. Yan M., Callum J., Lin Y. Hyperhemolysis associated with marginal zone lymphoma. Leuk Lymphoma 2014, 4:1-3.
38. Wahl S., Quirolo K.C. Current issues in blood transfusion for sickle cell disease. Curr Opin Pediatr 2009, 21:15-21.
39. Rosse W.F., Gallagher D., Kinney T.R., Castro O., Dosik H., Moohr J., et al. Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990, 76:1431-1437.
40. Vichinsky E.P., Earles A., Johnson R.A., Hoag M.S., Williams A., Lubin B. Alloimmunisation in sickle cell anaemia and transfusion of racially unmatched blood. N Engl J Med 1990, 322:1617-1621.
41. Win N. Hyperhaemolysis syndrome in sickle cell disease. Expert Rev Hematol 2009, 2:111-115.
42. Mollison P.L., Enlgefiret C.P., Contreras M. Blood transfusion in clinical medicine 1993, 532. Blackwell, Oxford. 9th ed.
43. Ness P.M., Shirley R.S., Thoman S.K., Buck S.A. The differentiation of delayed serologic and delayed haemolytic transfusion reactions: incidence, long-term serologic findings and clinical significance. Transfusion 1990, 30:688-693.
44. Salama A., Mueller-Eckhardt C. Delayed haemolytic transfusion reactions; evidence for complement activation involving allogeneic and autologous red cells. Transfusion 1984, 24:188-193.
45. Garratty G. Severe reactions associated with transfusion of patients with sickle cell disease. Transfusion 1997, 37:357-361.
46. Test S.T., Woolworth V.S. Defective regulation of complement by the sickle erythrocyte: evidence for a defect in control of membrane attack complex function. Blood 1994, 83:842-852.
47. Malasit P., Mahasorn W., Mongkolsapaya J., Singhathong B., Fucharoen S., Wasi P., et al. Presence of immunoglobulins, C3 and cytolytic C5b-9 complement components on the surface of erythrocytes from patients with beta-thalassaemia/HbE disease. Br J Haematol 1997, 96:507-513.
48. Friedman D.F., Lukas M.B., Jawad A., Larson P.J., Ohene-Frempong K., Manno C.S. Alloimmunization to platelets in heavily transfused patients with sickle cell disease. Blood 1996, 88:3216-3222.
49. Garratty G. The James Blundell Award Lecture 2007: do we really understand immune red cell destruction?. Transfus Med 2008, 18:321-324.
50. Benson K., Agosti S.J., Latoni-Bendetti G.E., Leparc G.F. Acute and delayed haemolytic transfusion reactions secondary to HLA alloimmunization. Transfusion 2003, 43:753-757.
51. Takeuchi C., Ohto H., Hiroyasu S., Yasuda H., Ono S., Ogata T. Delayed and acute haemolytic transfusion reactions resulting from red cell antibodies and red cell reactive HLA antibodies. Transfusion 2005, 45:1925-1929.
52. Muro M., Palacios S., Moya-Quiles R., Candela M., Alvarz-Lopez R. Acute haemolytic transfusion reactions secondary to human leucocyte antigen alloimmunization. Int J Lab Hematol 2008, 30:84-86.
53. a. Transfusion 1979, 19:609.
54. Weitkamp L.A., Johnson S.T., Larson L.B., Hackbarth S.A., Pierce K.L., Oesterling K.F. Severe symptomatic hemolytic transfusion reactions secondary to strong HLA antibody directed toward A2 public and private epitopes. Transfusion 1993, 33:55S.
55. Chou S., Jackson T., Vege S., Smith-Whitley K., Friedman D.F., Westhoff C.M. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 2013, 122:1062-1071.
56. Castilho L., Rios M., Bianco C., Pellegrino J., Alberto F.L., Saad S.T., et al. DNA-based typing of blood groups for the management of multiply-transfused sickle cell disease patients. Transfusion 2002, 42:232-238.
57. Pham B.N., Peyrard T., Juszczak G., Beolet M., Deram G., Martin-Blanc S., et al. Analysis of RhCE variants among 806 individuals in France: considerations for transfusion safety with emphasis on patients with sickle cell disease. Transfusion 2011, 51:1249-1260.
58. Chou S.T., Westhoff C.M. Molecular biology of the Rh system: clinical considerations for transfusion in sickle cell disease. Hematology Am Soc Hematol Educ Program 2009, 178-184.
59. http://www.shotuk.org/home/.
60. http://www.nhsbt.nhs.uk/download/board_papers/mar14/Integrated_Transfusion_Services_Update.pdf.